一、董事会会议召开情况 债券代码：111023 债券简称：利柏转债 江苏利柏特股份有限公司第五届 登录新浪财经APP 搜索【信披】查看更多考评等级 董事会第十六次会议决议公告 证券代码：605167 证券简称：利柏特 公告编号：2025-029 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 江苏利柏特股份有限公司（以下简称"公司"）第五届董事会第十六次会议于2025年7月31日（星期四） 在公司会议室以现场结合通讯的方式召开。会议通知已于2025年7月25日以书面及邮件等方式送达全体 董事。 本次会议应出席董事9人，实际出席董事9人。会议由董事长沈斌强先生主持，监事、高管列席。本次会 议召开符合有关法律、行政法规、部门规章、规范性文件和《公司章程》的规定。 二、董事会会议审议情况 （一）审议通过《关于使用募集资金置换预先投入的自筹资金的议案》 具体内容详见披露于上海证券交易所网站（www.sse.com.cn）的《江苏利柏特股份有限公司关于使用募 集资金置换预先投入募投项目及已支付发行费用的自筹资金公告》（公告编号：2025 ...

一、监事会会议召开情况 江苏利柏特股份有限公司（以下简称"公司"）第五届监事会第十六次会议 于 2025 年 7 月 31 日（星期四）在公司会议室以现场结合通讯的方式召开。会议 通知已于 2025 年 7 月 25 日以书面及邮件等方式送达全体监事。 本次会议应出席监事 3 人，实际出席监事 3 人。会议由监事会主席张英洁女 士主持，董事、高管列席。本次会议召开符合有关法律、行政法规、部门规章、 规范性文件和《公司章程》的规定。 二、监事会会议审议情况 （一）审议通过《关于使用募集资金置换预先投入的自筹资金的议案》 证券代码：605167 证券简称：利柏特 公告编号：2025-030 债券代码：111023 债券简称：利柏转债 江苏利柏特股份有限公司 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 （二）审议通过《关于使用募集资金向全资子公司提供借款以实施募投项 目的议案》 具体内容详见披露于上海证券交易所网站（www.sse.com.cn）的《江苏利柏 特股份有限公司关于使用募集资金向全资子公司提供借款以实施募投项目的公 ...

证券代码：605167 证券简称：利柏特 公告编号：2025-029 债券代码：111023 债券简称：利柏转债 江苏利柏特股份有限公司 本议案已经董事会审计委员会审议通过。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 二、董事会会议审议情况 具体内容详见披露于上海证券交易所网站（www.sse.com.cn）的《江苏利柏 特股份有限公司关于使用募集资金向全资子公司提供借款以实施募投项目的公 告》（公告编号：2025-032） 一、董事会会议召开情况 （一）审议通过《关于使用募集资金置换预先投入的自筹资金的议案》 江苏利柏特股份有限公司（以下简称"公司"）第五届董事会第十六次会议 于 2025 年 7 月 31 日（星期四）在公司会议室以现场结合通讯的方式召开。会议 通知已于 2025 年 7 月 25 日以书面及邮件等方式送达全体董事。 具体内容详见披露于上海证券交易所网站（www.sse.com.cn）的《江苏利柏 特股份有限公司关于使用募集资金置换预先投入募投项目及已支付发行费用的 自筹资金公告》（公告编号：2025 ...

证券代码：605167 证券简称：利柏特 公告编号：2025-031 债券代码：111023 债券简称：利柏转债 江苏利柏特股份有限公司 关于使用募集资金置换预先投入募投项目及 已支付发行费用的自筹资金公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ? 江苏利柏特股份有限公司（以下简称"公司"）拟使用募集资金置换预先 投入募集资金投资项目的自筹资金为人民币 49,608.35 万元，使用募集资金置换 已支付发行费用的自筹资金为人民币 118.84 万元，合计人民币 49,727.19 万元， 符合募集资金到账后 6 个月内进行置换的规定。 一、募集资金基本情况 根据中国证券监督管理委员会出具的《关于同意江苏利柏特股份有限公司向 不特定对象发行可转换公司债券注册的批复》（证监许可〔2025〕1173 号），公 司本次向不特定对象发行了 7,500,000 张可转换公司债券，每张面值为人民币 100 元，募集资金总额为人民币 75,000.00 万元。扣除各项发行费用（不含税）人民 币 565.63 万元，实 ...

Core Points - The company plans to use part of its idle raised funds for cash management to enhance fund utilization efficiency while ensuring safety and not affecting the normal investment plans [3][5] - The total amount for cash management is capped at RMB 247 million [3][4] - The company has issued 7.5 million convertible bonds, raising a total of RMB 750 million, with a net amount of RMB 744.34 million after deducting issuance costs [1][2] Fund Management - The raised funds will be stored in a dedicated account with regulatory agreements in place to protect investor rights [2] - The cash management will involve investing in high-safety, high-liquidity principal-protected products with a maturity of no more than 12 months [3][4] - The cash management period is valid for 12 months from the board's approval date, allowing for rolling use of funds within the specified limit [3][4] Investment Projects - The raised funds, after deducting related issuance costs, will be allocated to specific investment projects as outlined in the bond issuance prospectus [2] Risk Management - The company aims to control investment risks by selecting safe and liquid financial products, with measures in place to monitor and address any potential risks [5] - The cash management activities will not alter the intended use of the raised funds or impact the normal execution of investment projects [5][6] Approval Process - The proposal for cash management was approved in the 16th meeting of the fifth board and supervisory committee, and does not require shareholder approval [4][6] Sponsor's Opinion - The sponsor has confirmed that the cash management proposal complies with relevant regulations and does not involve changing the intended use of the raised funds [5][6]

Key Points - The company plans to provide a loan of RMB 744.34 million to its wholly-owned subsidiary, Nantong Libat Heavy Industry Co., Ltd., to implement a fundraising project [1][3][5] - The loan amount includes corresponding income such as interest and net cash management income, with the actual amount based on the balance of the fundraising account [1][3] - The board of directors approved the loan proposal on July 31, 2025, and it does not require shareholder approval [1][7] - The total amount raised from the issuance of convertible bonds was RMB 750 million, with a net amount of RMB 744.34 million after deducting issuance costs [1][2] - The loan is intended solely for the implementation of the "Nantong Libat Heavy Industry Co., Ltd. Large Industrial Module Manufacturing Project" and cannot be used for other purposes [3][5] - The loan term is five years, with interest rates based on the latest published loan market quotation rates [3][5] - Nantong Libat Heavy Industry Co., Ltd. is a wholly-owned subsidiary of the company, established on September 18, 2023, with a registered capital of RMB 200 million [4][5] - The company has established a special account for the management of the raised funds and signed regulatory agreements with relevant parties to ensure proper use [2][6] - The company and its subsidiary will comply with relevant regulations regarding the management and use of raised funds [6][7]

（文章来源：证券日报） 证券日报网讯 8月1日晚间，利柏特发布公告称，公司第五届董事会第十六次会议审议通过了《关于使 用募集资金置换预先投入的自筹资金的议案》《关于使用募集资金向全资子公司提供借款以实施募投项 目的议案》《关于使用部分闲置募集资金进行现金管理的议案》。 ...

证券日报网讯 8月1日晚间，利柏特发布公告称，公司第五届监事会第十六次会议审议通过了《关于使 用募集资金置换预先投入的自筹资金的议案》《关于使用募集资金向全资子公司提供借款以实施募投项 目的议案》《关于使用部分闲置募集资金进行现金管理的议案》。 （编辑 任世碧） ...

Group 1 - Yabont Chemical signed a 10-year supply strategic agreement with Jiangsu Hengrui Medicine to enhance collaboration in the pharmaceutical supply chain, effective from August 1, 2025 [1] - Wei Hua New Materials plans to acquire controlling interest in Jiangsu Heyutai Chemical to extend its product chain and improve competitiveness, currently in the planning stage [2] - Fujirey received a government subsidy of 2.0074 million yuan, expected to positively impact profits in 2025 [4] Group 2 - Hangzhou Garden won the land use rights for a plot in Yuhang District for 130 million yuan, planning to build a smart ecological design R&D headquarters with a total investment of no more than 450 million yuan [5] - Baotai's clinical trial for BAT5906, a recombinant anti-VEGF monoclonal antibody, received approval for new indications, aiming to accelerate commercialization [6] - Weisheng Information won multiple projects with a total bid amount of 110 million yuan, including significant contracts with Southern Power Grid and State Grid [8] Group 3 - Dong'an Power reported a 27.37% year-on-year increase in engine sales for July, totaling 34,500 units [13] - Hanma Technology's truck sales reached 956 units in July, marking a 42.69% year-on-year increase [14] - Jiangsu Bank's executives received regulatory approval for their positions, effective immediately [15] Group 4 - Chip Origin expects Q2 revenue of 584 million yuan, a 49.90% increase quarter-on-quarter, with significant growth in intellectual property licensing fees [24] - Dream Network Technology plans to establish a high-end equipment industry investment fund with a target fundraising of 2 billion yuan [26] - Hefei Urban Construction and China Real Estate Development won land use rights for a residential plot in Hefei for 980 million yuan [28] Group 5 - Lu Kang Pharmaceutical's subsidiary received a drug registration certificate for a new medication for erectile dysfunction [28] - Lifan Pharmaceutical's Mesalazine enteric-coated tablets received a drug registration certificate for treating ulcerative colitis [29] - Yahu Pharmaceutical's APL-1401 clinical trial for ulcerative colitis showed positive preliminary results [30]

国泰海通证券股份有限公司 关于江苏利柏特股份有限公司 根据中国证券监督管理委员会出具的《关于同意江苏利柏特股份有限公司向 不特定对象发行可转换公司债券注册的批复》（证监许可〔2025〕1173 号），公司 本次向不特定对象发行了 7,500,000 张可转换公司债券，每张面值为人民币 100 元，募集资金总额为人民币 75,000.00 万元。扣除各项发行费用（不含税）人民 币 565.63 万元，实际募集资金净额为人民币 74,434.37 万元。上述募集资金已 于 2025 年 7 月 9 日全部到账，中汇会计师事务所（特殊普通合伙）于 2025 年 7 月 9 日对本次募集资金到账情况进行了审验，并出具了中汇会验［2025］10005 号《验证报告》。 为规范募集资金存放、管理和使用，切实保护投资者权益，公司已对募集资 金进行了专户存储，并与保荐机构以及募集资金专户存储银行分别签订了《募集 资金专户存储三方监管协议》和《募集资金专户存储四方监管协议》。 二、募集资金投资项目情况 根据《江苏利柏特股份有限公司向不特定对象发行可转换公司债券募集说明 书》，本次向不特定对象发行可转换公司债券募集资金扣除相关发 ...